Xanthine oxidase: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
No edit summary
Line 3: Line 3:
==Overview==
==Overview==
[[Image:XanthineOxidase-1FIQ.png|thumb|Xanthine Oxidase]]
[[Image:XanthineOxidase-1FIQ.png|thumb|Xanthine Oxidase]]
{{SI}}
The [[enzyme]] '''xanthine oxidase''', or '''XO''', (bovine milk enzyme is {{PDB|1FIQ}}, {{EC number|1.17.3.2}}) catalyzes the [[oxidation]] of [[hypoxanthine]] to [[xanthine]] and can further catalyze the oxidation of xanthine to [[uric acid]]
The [[enzyme]] '''xanthine oxidase''', or '''XO''', (bovine milk enzyme is {{PDB|1FIQ}}, {{EC number|1.17.3.2}}) catalyzes the [[oxidation]] of [[hypoxanthine]] to [[xanthine]] and can further catalyze the oxidation of xanthine to [[uric acid]]



Revision as of 11:52, 11 June 2009

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Xanthine Oxidase

WikiDoc Resources for Xanthine oxidase

Articles

Most recent articles on Xanthine oxidase

Most cited articles on Xanthine oxidase

Review articles on Xanthine oxidase

Articles on Xanthine oxidase in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Xanthine oxidase

Images of Xanthine oxidase

Photos of Xanthine oxidase

Podcasts & MP3s on Xanthine oxidase

Videos on Xanthine oxidase

Evidence Based Medicine

Cochrane Collaboration on Xanthine oxidase

Bandolier on Xanthine oxidase

TRIP on Xanthine oxidase

Clinical Trials

Ongoing Trials on Xanthine oxidase at Clinical Trials.gov

Trial results on Xanthine oxidase

Clinical Trials on Xanthine oxidase at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Xanthine oxidase

NICE Guidance on Xanthine oxidase

NHS PRODIGY Guidance

FDA on Xanthine oxidase

CDC on Xanthine oxidase

Books

Books on Xanthine oxidase

News

Xanthine oxidase in the news

Be alerted to news on Xanthine oxidase

News trends on Xanthine oxidase

Commentary

Blogs on Xanthine oxidase

Definitions

Definitions of Xanthine oxidase

Patient Resources / Community

Patient resources on Xanthine oxidase

Discussion groups on Xanthine oxidase

Patient Handouts on Xanthine oxidase

Directions to Hospitals Treating Xanthine oxidase

Risk calculators and risk factors for Xanthine oxidase

Healthcare Provider Resources

Symptoms of Xanthine oxidase

Causes & Risk Factors for Xanthine oxidase

Diagnostic studies for Xanthine oxidase

Treatment of Xanthine oxidase

Continuing Medical Education (CME)

CME Programs on Xanthine oxidase

International

Xanthine oxidase en Espanol

Xanthine oxidase en Francais

Business

Xanthine oxidase in the Marketplace

Patents on Xanthine oxidase

Experimental / Informatics

List of terms related to Xanthine oxidase

The enzyme xanthine oxidase, or XO, (bovine milk enzyme is PDB: 1FIQ​, EC 1.17.3.2) catalyzes the oxidation of hypoxanthine to xanthine and can further catalyze the oxidation of xanthine to uric acid

Reaction

  • hypoxanthine + O2 + H2O ↔ xanthine + H2O2
  • xanthine + O2 + H2O ↔ uric acid + H2O2

Protein structure

The protein is large, having a molecular weight of 270,000, and has 2 flavin molecules (bound as FAD), 2 molybdenum atoms, and 8 iron atoms bound per enzymatic unit. The molybdenum atoms are contained as molybdopterin cofactors and are the active sites of the enzyme. The iron atoms are part of [2Fe-2S] ferredoxin iron-sulfur clusters and participate in electron transfer reactions.

Active site and mechanism of xanthine oxidase

The active site of XO is composed of a molybdopterin unit with the molybdenum atom also coordinated by terminal oxygen (oxo), sulfur atoms and a terminal hydroxide. In the reaction with xanthine to form uric acid, an oxygen atom is transferred from molybdenum to xanthine. The reformation of the active molybdenum center occurs by the addition of water. Like other known molybdenum-containing oxidoreductases, the oxygen atom introduced to the substrate by XO originates from water rather than from dioxygen (O2).

Xanthine oxidase and disease

In humans, xanthine oxidase is normally found in the liver and not free in the blood. During severe liver damage, xanthine oxidase is released into the blood, so a blood assay for XO is a way to determine if liver damage has happened. As well, because xanthine oxidase is a metabolic pathway for uric acid formation, the xanthine oxidase inhibitor allopurinol is used in the treatment of gout.

Xanthinuria is a rare genetic disorder where the lack of xanthine oxidase leads to high concentration of xanthine in blood and can cause health problems such as renal failure. There is no specific treatment, sufferers are advised by doctors to avoid foods high in purine and to maintain a high fluid intake.

See also

References

  • Hille R (2005). "Molybdenum-containing hydroxylases". Arch. Biochem. Biophys. 433 (1): 107–16. doi:10.1016/j.abb.2004.08.012. PMID 15581570.
  • Harrison R (2002). "Structure and function of xanthine oxidoreductase: where are we now?". Free Radic. Biol. Med. 33 (6): 774–97. PMID 12208366.

External links


Template:WikiDoc Sources

de:Xanthinoxidase